Experion Reports Third Straight Quarter of Record Revenue Growth in Q3 and Reports on Financial and Operational Highlights

VANCOUVER, BC / ACCESSWIRE / October 29, 2020 / Experion Holdings Ltd. (the “Company” or “Experion”) (TSXV:EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), a cultivator and processor of premium cannabis products, is pleased to announce its financial results for its third quarter and for the period ended August 31, 2020.

Jarrett Malnarich, CEO of Experion, stated, “This is our third consecutive quarter of sequential sales growth, which is a result of our continued focus on expanding our product offerings and building our brand profile as a premium craft producer nationally. Experion’s Gross Revenue of $2.1 million in Q3 2020 represents an increase of 24% over the previous quarter, and in the first 3 quarters, our YTD Gross Revenue is  397% over the same period 2019. The Company’s ability to cultivate and accumulate flower at industry-leading levels and distribute it across Canada validates the strategic plan. We are an industry-leading producer, processor and distributor of premium cannabis products, and we know that our expanded line of offerings will lead to increased revenues and profitability in the coming quarters”.


  • Revenue increased 24% in the Third quarter compared to the Second quarter of 2020; YTD revenue of $4,647,635 million exceeding the same nine months period in 2019 by 397%.
  • YTD operating expenses by decreased by $1,824,577 or 42% compared to the same period in the prior year.
  • Adjusted EBITDA of $(1,110,275) for the nine months ending August 31, 2020 represents an increase of $2,114,123 million compared to the same period in the prior year.
  • Well positioned balance sheet with total assets of $15,392,483 million and net working capital of $$4,438,370 million with no debt.
  • Processed and sold 530,267 grams of premium dried flower through retail distribution compared to 166,342 grams for the same period in 2019, an increase of 219%.


  • Experion’s consumer brand, Citizen Stash, continues to gain traction in the marketplace throughout five provinces and two territories across Canada; with the most recent being Ontario.
  • Experion shipped its largest order to date, to Ontario in September 2020, and has received over $1 Million in orders since September.
  • Received Health Canada approval license amendment for derivatives in late second quarter of 2020 and the Company plans to launch a series of in-demand concentrates and edible products under its premium Citizen Stash brand in the coming quarter.
  • Experion executed a supply agreement with leading edible manufacture Lyf Foods for the supply of high end, vegan infused gummy edibles.
  • Citizen Stash continued to build a solid reputation for premium cannabis products and was nominated as a top 10 flower in the Cannabis Consumer Awards 2020.

The Management’s Discussion and Analysis and the accompanying financial statements and notes for the period ended August 31, 2020, are available under the Company’s profile on SEDAR at www.sedar.com.

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com


This news release contains “forward-looking statements” and “forward-looking information” (collectively referred to herein as “forward-looking statements”) within the meaning of applicable securities legislation. Such forward-looking statements include, without limitation, forecasts, estimates, expectations and objectives for future operations that are subject to a number of material factors, assumptions, risks and uncertainties, many of which are beyond the control of the Company.

Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “continues”, “future”, “forecasts”, “potential”, “outlook” and similar expressions, or are events or conditions that “will”, “would”, “may”, “likely”, “could”, “should”, “can”, “typically”, “traditionally” or “tends to” occur or be achieved. This news release contains forward-looking statements, pertaining to, among other things, the following: The Company’s capital spending forecast and expectations of how it will be funded; near-term impacts from the COVID-19 pandemic; the Company’s capital management strategy and financial position; the impact of governmental and Company measures implemented in response to the COVID-19 pandemic; the Company’s outlook, activity levels, supply chains and sales channels; loss of markets; further legislative and regulatory developments involving cannabis or otherwise affecting the Company’s business or its consumers generally, including delays in the issuance of licenses; competition; currency and interest rate fluctuations; and marketing costs.

Although the Company believes that the material factors, expectations and assumptions expressed in such forward-looking statements are reasonable based on information available to it on the date such statements are made, undue reliance should not be placed on the forward-looking statements because the Company can give no assurances that such statements and information will prove to be correct and such statements are not guarantees of future performance. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties.

Actual performance and results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to: known and unknown risks, including those set forth in the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis (“MD&A”) (a copy of which can be found under Experion’s profile on SEDAR at www.sedar.com); a significant expansion of COVID-19 pandemic and the impacts thereof; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategy; integration of acquisitions, competition, and uncertainties resulting from potential delays or changes in plans with respect to acquisitions, development projects or capital expenditures and changes in legislation; stock market volatility and the inability to access sufficient capital from external and internal sources; general economic, market or business conditions including those in the event of an epidemic, natural disaster or other event; global economic events; changes to the Company’s financial position and cash flow; the availability of qualified personnel, management or other key inputs; currency exchange fluctuations; changes in political and security stability; potential industry developments; and other unforeseen conditions which could impact the Company. Accordingly, readers should not place undue importance or reliance on the forward-looking statements. Readers are cautioned that the foregoing list of factors is not exhaustive and should refer to “Risk Factors” set out in the MD&A.

Statements, including forward-looking statements, contained in this news release are made as of the date they are given and the Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.